Seattle, WA, United States of America

Jiho Kim

This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignees: Hdt Bio Corp., Htd Bio Corp., University of Washington. Active years: 2025-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jiho Kim. Retrieved from https://idiyas.com/inventor/jiho-kim-dim0a300

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 50.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2025-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Jiho Kim - Innovator in Cancer Therapy

Introduction

Jiho Kim is a prominent inventor based in Seattle, WA (US). He has made significant contributions to the field of cancer therapy through his innovative research and development efforts. His work focuses on creating effective treatment options for cancer patients.

Latest Patents

Jiho Kim holds a patent titled "Cancer Therapy Compositions and Uses Thereof." This patent represents his commitment to advancing medical science and improving therapeutic strategies for cancer treatment. He has 1 patent to his name, showcasing his dedication to innovation in this critical area.

Career Highlights

Jiho Kim is currently employed at Hdt Bio Corp, where he continues to work on groundbreaking research in cancer therapy. His role at the company allows him to collaborate with other experts in the field and contribute to the development of new treatment modalities.

Collaborations

One of his notable collaborators is Steven Gregory Reed. Together, they work on various projects aimed at enhancing cancer treatment options and improving patient outcomes.

Conclusion

Jiho Kim's contributions to cancer therapy through his patent and work at Hdt Bio Corp highlight his role as an innovator in the medical field. His efforts are paving the way for advancements that could significantly impact cancer treatment in the future.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…